7/2/2014

Bristol-Myers Squibb has issued a voluntary recall of six lots of its injected anticoagulant Coumadin in 5-milligram vials after discovering visible particulate matter seen in unreleased samples. The injected formulation, discontinued earlier this year, is primarily administered by professionals in a health care setting.

Related Summaries